MedTrace Logo

Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015

NCT05728671 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-02-15

No results posted yet for this study

Summary

The study's primary objective is to determine the bioavailability of two solid formulations of IP2015 compared to a liquid formulation of IP2015 in healthy male subjects

Conditions

  • Bioavailability

Interventions

DRUG

IP2015

Test drug

Sponsors & Collaborators

  • Initiator Pharma

    lead INDUSTRY

Principal Investigators

  • Sandy Connell, MD · MAC UK

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-16
Primary Completion
2023-05-16
Completion
2023-07-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05728671 on ClinicalTrials.gov